Robocath's R-One Robotic Device Earns CE Mark Approval to Assist in Coronary Interventions

 

February 26, 2019—Robocath announced that it has obtained European CE Mark approval of its R-One device for robotic-assisted treatment of coronary artery disease.

According to the company, the R-One robotic device assists interventional cardiologists in angioplasty procedures by enabling precision technologies that complement existing methods, thereby improving procedures and the working environment. R-One's open architecture makes it compatible with market-leading devices and catheterization labs.

With the approval, Robocath is planning to raise financing to support commercialization of the device over the next few years in Europe and the Middle East. Additionally, the company stated that it is finalizing strategic distribution partnerships for an expected launch in 2020.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.